Medroxyprogesterone acetate is an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation for in vitro fertilization.
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
To investigate the use of medroxyprogesterone acetate (MPA) to prevent LH surge during
controlled ovarian hyperstimulation (COH) and to compare cycle characteristics and
pregnancy outcomes in subsequently frozen-thawed ET (FET) cycles.
[1
]
Department of Assisted Reproduction, Shanghai Ninth People's Hospital, Shanghai Jiaotong
University School of Medicine, Shanghai, People's Republic of China. Electronic address:
Kuangyanp@126.com.
[2
]
Department of Assisted Reproduction, Shanghai Ninth People's Hospital, Shanghai Jiaotong
University School of Medicine, Shanghai, People's Republic of China.
[3
]
Department of Obstetrics and Gynecology, Kaplan Medical Center, Rehovot, Israel.